Kuros to Begin Fibrin-PTH Clinical Trial in Spinal Fusion
Kuros Biosciences gained FDA approval for its IND application to initiate a Phase IIA clinical trial evaluating Fibrin-PTH orthobiologic in single-level TLIF to treat degenerative disc disease, with autograft as comparator. Sep 03, 2019